Browse > Article

Pulmonary Lipiodol Accumulation after Transarterial Chemoembolization: CT Findings and Its Radiologic Outcomes  

Youn, In-Young (Department of Radiology, Chung-Ang University Medical Center, Chung-Ang University College of Medicine)
Chong, Se-Min (Department of Radiology, Chung-Ang University Medical Center, Chung-Ang University College of Medicine)
Kwak, Byung-Kook (Department of Radiology, Chung-Ang University Medical Center, Chung-Ang University College of Medicine)
Shim, Hyung-Jin (Department of Radiology, Chung-Ang University Medical Center, Chung-Ang University College of Medicine)
Seo, Gi-Young (Department of Radiology, Chung-Ang University Medical Center, Chung-Ang University College of Medicine)
Seo, Jae-Seung (Department of Radiology, Chung-Ang University Medical Center, Chung-Ang University College of Medicine)
Kim, Jae-Kyun (Department of Radiology, Chung-Ang University Medical Center, Chung-Ang University College of Medicine)
Publication Information
Journal of the Korean Society of Radiology / v.65, no.6, 2011 , pp. 577-583 More about this Journal
Abstract
Purpose: To evaluate CT findings and radiologic outcomes of pulmonary lipiodol accumulation (PLA) after transarterial chemoembolization (TACE). Materials and Methods: This retrospective study involved 488 TACEs for hepatocellular carcinoma (HCC) (n = 160) and hepatic metastasis for non-hepatic malignancies (n = 7) in 167 patients. We reviewed the patient clinicoradiologic findings before and after TACE and calculated the incidence of PLA and PLA resolution time after initial CT and after TACE. Results: Lipiodol accumulation in the lungs was seen under CT after TACE in seven patients (M : F = 6 : 1, mean age 61 years). The incidence of PLA at CT was 4.1% (7/167 patients). In five patients, associated intrathoracic abnormalities including pleural effusion with (n = 3) or without consolidation (n = 2) were revealed at CT scans. The CT resolution time and PLA recovery time were 56 ${\pm}$ 54 days and 66 ${\pm}$ 52 days, respectively. Conclusion: The recovery time for lipiodol accumulation was 66 days. It is believed that the clinical and radiologic outcome of PLA without respiratory failure is promising, and conservative treatment will suffice when lipiodol accumulation in the lungs is seen in CT images after TACE.
Keywords
Lung; Iodized Oils; Chemoembolization, Therapeutic; Tomography, Spiral Computed;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Xia J, Ren Z, Ye S, Sharma D, Lin Z, Gan Y, et al. Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. Eur J Radiol 2006;59:407-412   DOI   ScienceOn
2 Lee KH, Sung KB, Lee DY, Park SJ, Kim KW, Yu JS. Transcatheter arterial chemoembolization for hepatocellular carcinoma: anatomic and hemodynamic considerations in the hepatic artery and portal vein. Radiographics 2002;22:1077-1091
3 Chung JW, Park JH, Im JG, Han JK, Han MC. Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1993;187:689-693
4 Tajima T, Honda H, Kuroiwa T, Yabuuchi H, Okafuji T, Yosimitsu K, et al. Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer. J Vasc Interv Radiol 2002;13: 893-900   DOI   ScienceOn
5 Choi SY, Goo JM, Chun HJ, Han DH. Lipiodol can simulate cement embolism in patients having undergone vertebroplasty due to metastasis from hepatocellular carcinoma. AJNR Am J Neuroradiol 2010;31:E2-E3   DOI
6 Wu GC, Perng WC, Chen CW, Chian CF, Peng CK, Su WL. Acute respiratory distress syndrome after transcatheter arterial chemoembolization of hepatocellular carcinomas. Am J Med Sci 2009;338:357-360   DOI   ScienceOn
7 Raoul JL, Bourguet P, Bretagne JF, Duvauferrier R, Coornaert S, Darnault P, et al. Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology 1988;168:541-545
8 Lin MT, Kuo PH. Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma. JRSM Short Rep 2010;1:6   DOI
9 Fraimow W, Wallace S, Lewis P, Greening RR, Cathcart RT. Changes in pulmonary function due to lymphangiography. Radiology 1965;85:231-241
10 Samejima M, Tamura S, Kodama T, Yuuki Y, Takasaki J, Sekiva R, et al. [Pulmonary complication following intra-arterial infusion of lipiodol-adriamycin emulsion for hepatocellular carcinoma, report of a case]. Nihon Igaku Hoshasen Gakkai Zasshi 1990;50:24-28
11 Lorcher U, Peters J, Kollath J. [Changes in the lungs and pleura following chemoembolization of liver tumors with mitomycin-lipiodol]. Rofo 1990;152:569-573   DOI
12 Charnsangavej C, Chuang VP, Wallace S, Soo CS, Bowers T. Angiographic classification of hepatic arterial collaterals. Radiology 1982;144:485-494
13 Koehler RE, Korobkin M, Lewis F. Arteriographic demonstration of collateral arterial supply to the liver after hepatic artery ligation. Radiology 1975;117:49-54
14 Han D, Lee KS, Franquet T, Muller NL, Kim TS, Kim H, et al. Thrombotic and nonthrombotic pulmonary arterial embolism: spectrum of imaging findings. Radiographics 2003;23: 1521-1539   DOI   ScienceOn
15 Rossi SE, Goodman PC, Franquet T. Nonthrombotic pulmonary emboli. AJR Am J Roentgenol 2000;174:1499-1508   DOI   ScienceOn